Your browser doesn't support javascript.
loading
Multiple non-syndromic basal cell carcinoma with the chest as primary site and lung metastases: A rare case.
Roditis, Konstantinos; Metaxas, George; Neofotistou, Ourania; Papaparaskeva, Kleo; Koutsoumbi, Aikaterini; Louis, Konstantinos.
Afiliação
  • Roditis K; Department of Vascular Surgery, Korgialenio-Benakio Hellenic Red Cross Hospital, Athens.
  • Metaxas G; Junior Doctors' Network-Hellas (JDN-Hellas), Athens.
  • Neofotistou O; 2 Surgical Department, Helena Venizelou General and Maternity District Hospital, Athens.
  • Papaparaskeva K; Department of Dermatology, Konstantopouleio Neas Ionias-Patission General Hospital, Nea Ionia, Athens.
  • Koutsoumbi A; Department of Pathology, Konstantopouleio Neas Ionias-Patission General Hospital, Nea Ionia, Athens.
  • Louis K; Department of Pathology, Helena Venizelou General and Maternity District Hospital, Athens.
Dermatol Reports ; 13(2): 9106, 2021 Aug 01.
Article em En | MEDLINE | ID: mdl-34497699
Basal cell carcinoma (BCC) is the most commonly diagnosed cancer in humans, usually affecting elderly Caucasian men and skin regions mostly exposed to the sun, that rarely metastasizes. We report an unusual and aggressive case of multiple, non-syndromic metastatic BCC with an uncommon primary site in the chest and pulmonary metastases, treated successfully with surgery and vismodegib. A 51-year-old woman presented with a large pigmentary lesion of the chest, close to the sternum. She had the lesion for > 25 years and lately noticed multiple facial lesions. The diagnosis of multiple BCC was suspected and a punch biopsy of the primary lesion was performed. Diagnosis was confirmed by immunohistochemistry (BerEp4+, EMA- phenotype). After excision, staging with a thorax computed tomography scan revealed metastatic micro-nodules in the left lung, confirmed histologically after video-assisted thoracic surgical biopsy. Adjuvant chemotherapy with vismodegib was proposed and administered. At 30 days follow-up, thorax computed tomography scan was unaltered and her facial lesions showed significant regression. Although prognosis remains poor, early diagnosis and prompt management complimented by novel biological agents, like vismodegib, targeting disease pathogenesis, seems to bring promising results.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Dermatol Reports Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Dermatol Reports Ano de publicação: 2021 Tipo de documento: Article